These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10628357)

  • 1. Relationship between cytotoxic activity and dipole moment for phthalimido- and chloroethyl-phenothiazines.
    Kurihara T; Motohashi N; Sakagami H; Molnár J
    Anticancer Res; 1999; 19(5B):4081-3. PubMed ID: 10628357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of phenothiazine-related compounds.
    Nagy S; Argyelan G; Molnár J; Kawase M; Motohashi N
    Anticancer Res; 1996; 16(4A):1915-8. PubMed ID: 8712720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between biological activity and dipole moment in benzo[a]phenothiazines.
    Motohashi N; Kurihara T; Yamanaka W; Satoh K; Sakagami H; Molnár J
    Anticancer Res; 1997; 17(5A):3431-5. PubMed ID: 9413182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic structure and cytotoxic activity of "half-mustard type" phenothiazines by MM3 and PM3 methods.
    Kurihara T; Nojima K; Sakagami H; Motohashi N; Molnár J
    Anticancer Res; 1999; 19(5B):3895-9. PubMed ID: 10628328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds.
    Sakagami H; Takahashi H; Yoshida H; Yamamura M; Fukuchi K; Gomi K; Motohashi N; Takeda M
    Anticancer Res; 1995; 15(6B):2533-40. PubMed ID: 8669819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
    Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between structure and diverse biological activities of "half-mustard type" phenothiazines.
    Motohashi N; Kurihara T; Satoh K; Sakagami H; Molnár J
    Anticancer Res; 1997; 17(6D):4403-6. PubMed ID: 9494541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulating activities on cellular cytotoxicity and the blast transformation of human lymphocytes by 10-[n-(phthalimido)alkyl-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10 H-phenothiazin-10-yl)alkyl-1-ureas.
    Petri IB; Szekeres E; Varga E; Berek I; Molnár J; Berek L; Kawase M; Motohashi N
    Anticancer Res; 1996; 16(3A):1247-50. PubMed ID: 8702245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance reversal, anti-mutagenicity and antiretroviral effect of phthalimido- and chloroethyl-phenothiazines.
    Motohashi N; Kurihara T; Kawase M; Hevér A; Tanaka M; Szabo D; Nacsa J; Yamanaka W; Kerim A; Molnár J
    Anticancer Res; 1997; 17(5A):3537-43. PubMed ID: 9413199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activity of 1-[2-(chloroethyl)-3-(2-substituted-10H-phenothiazin-10-yl)alkyl- 1-urea s as potent anticancer agents.
    Motohashi N; Kawase M; Kurihara T; Hevér A; Nagy S; Ocsocvszki I; Tanaka M; Molnár J
    Anticancer Res; 1996; 16(5A):2525-32. PubMed ID: 8917346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of a protective immunity in mice against Escherichia coli by phenothiazines, 10-[n-(phthalimido)alkyl]-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazines-10-yl)alkyl-1 -ureas .
    Komatsu N; Motohashi N; Fujimaki M; Molnár J
    In Vivo; 1997; 11(1):13-6. PubMed ID: 9067767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
    Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
    Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenothiazine-anthraquinone donor-acceptor molecules: synthesis, electronic properties and DFT-TDDFT computational study.
    Zhang WW; Mao WL; Hu YX; Tian ZQ; Wang ZL; Meng QJ
    J Phys Chem A; 2009 Sep; 113(37):9997-10004. PubMed ID: 19705823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FT-IR, molecular structure, first order hyperpolarizability, NBO analysis, HOMO and LUMO and MEP analysis of 1-(10H-phenothiazin-2-yl)ethanone by HF and density functional methods.
    Vipin Das KG; Yohannan Panicker C; Narayana B; Nayak PS; Sarojini BK; Al-Saadi AA
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():162-71. PubMed ID: 25062062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of calculated molecular orbital energies of some phenothiazine compounds with MDR reversal properties.
    Hilgeroth A; Molnár A; Molnár J; Voigt B
    Eur J Med Chem; 2006 Apr; 41(4):548-51. PubMed ID: 16516350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrational spectroscopic (FT-IR, FT-Raman) and quantum chemical calculations of 1-(5,5-dioxido-10H-phenothiazin-10-yl)ethanone.
    Kaur M; Mary YS; Panicker CY; Varghese HT; Yathirajan HS; Byrappa K; Van Alsenoy C
    Spectrochim Acta A Mol Biomol Spectrosc; 2014; 120():445-55. PubMed ID: 24211803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of benzo[a]phenothiazines.
    Motohashi N; Kurihara T; Satoh K; Sakagami H; Mucsi I; Pusztai R; Szabó M; Molnár J
    Anticancer Res; 1999; 19(3A):1837-42. PubMed ID: 10470124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Thiazolo[5,4-b]phenothiazine Derivatives: Synthesis, Structural Characterization, and In Vitro Evaluation of Antiproliferative Activity against Human Leukaemia.
    Brem B; Gal E; Găină L; Silaghi-Dumitrescu L; Fischer-Fodor E; Tomuleasa CI; Grozav A; Zaharia V; Filip L; Cristea C
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
    Ramprasad J; Nayak N; Dalimba U
    Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.